Drugs with this side effect as MedDRA Preferred Term
- 5-ASA
- Renal failure: very rare, postmarketing
- Renal impairment: very rare
- 5-aza-2'-deoxycytidine
- 5-azacytidine
- 5-fluorocytosine
- BCNU
- BPTI
- Renal failure
- Renal impairment
- Benicar-HCT
- Bivalirudin
- CAS 76095-16-4
- CAS 76420-72-9
- Renal failure
- Renal impairment
- Cancidas
- Renal failure
- Renal impairment: 0% - 5.6%
- Carfilzomib
- D-penicillamine
- EACA
- Enfuvirtide
- Renal failure
- Renal impairment
- Eptifibatide
- FAMP
- FK463
- Renal failure
- Renal failure aggravated
- Renal impairment: postmarketing
- Forteo
- Gd-DTPA
- Ge-132
- Renal failure: postmarketing
- Renal impairment: postmarketing
- Glat copolymer
- Renal failure: postmarketing
- Goserelin
- Histrelin
- Renal failure aggravated
- Renal impairment
- K779
- Renal failure: postmarketing
- Renal impairment: postmarketing
- LY146032
- Renal failure: postmarketing, uncommon, 1.7% - 9.5%
- Renal impairment: postmarketing, uncommon, 1% - 1.7%
- Lisinopril
- Renal impairment: very rare, postmarketing, uncommon
- Meropenem anhydrous
- PCI-32765
- PGE1
- UDCA
- Renal failure
- Renal impairment
- VACV
- Renal failure: very rare, postmarketing
- Renal impairment: postmarketing, rare
- Vancocine
- Renal failure
- Renal impairment
- abacavir
- abacavir-lamivudine
- acetohydroxamic acid
- acyclovir
- Renal failure: very rare, postmarketing
- Renal impairment: very rare
- adefovir
- Renal failure: postmarketing
- Renal impairment
- adefovir dipivoxil
- Renal failure: postmarketing, common
- Renal impairment: postmarketing
- afatinib
- Renal failure: common
- Renal impairment: common
- aliskiren
- Renal impairment: uncommon
- amifostine
- amiodarone
- Renal impairment: postmarketing
- amoxicillin
- Renal impairment: very rare
- amphotericin B
- Renal failure
- Renal impairment
- amsacrine
- anagrelide
- Renal failure: 1-5%
- Renal impairment
- anthracycline
- Renal failure
- Renal impairment
- aprepitant
- aripiprazole
- arsenic
- Renal failure
- Renal impairment
- arsenic trioxide
- Renal failure
- Renal impairment
- atazanavir
- atenolol
- atorvastatin
- atovaquone
- Renal impairment: postmarketing
- axitinib
- azilsartan
- baclofen
- balsalazide
- Renal failure: postmarketing
- benzathine penicillin
- bortezomib
- Renal failure: 1%
- Renal impairment
- bosentan
- Renal failure
- Renal impairment
- bosutinib
- Renal failure
- Renal impairment
- bumetanide
- busulfan
- cabazitaxel
- caffeine
- candesartan
- Renal failure: postmarketing
- Renal impairment: postmarketing
- candesartan cilexetil
- Renal failure: postmarketing
- Renal impairment: postmarketing
- capecitabine
- Renal failure: 0.4%
- Renal impairment: 0.6%
- capreomycin
- captopril
- carbamazepine
- Renal failure: very rare
- Renal impairment: very rare
- carnitine
- carvedilol
- Renal failure: 0.1% - 1.6%
- cefazolin
- cefdinir
- Renal impairment: postmarketing
- cefepime
- Renal failure: postmarketing
- Renal impairment: postmarketing
- cefixime
- Renal impairment: postmarketing
- cefotaxime
- Renal impairment: postmarketing
- cefpodoxime
- Renal impairment: postmarketing
- ceftaroline
- ceftazidime
- Renal failure: postmarketing
- Renal impairment: postmarketing
- ceftriaxone
- Renal impairment: postmarketing
- cefuroxime
- Renal impairment: postmarketing
- cephem
- Renal impairment: postmarketing
- cidofovir
- Renal failure: postmarketing
- cilazapril
- Renal failure: postmarketing, 0.09% - 0.1%
- Renal impairment: postmarketing
- cimetidine
- Renal failure
- Renal impairment
- ciprofloxacin
- Renal failure: postmarketing, rare, uncommon
- Renal impairment: uncommon
- cisplatin
- cladribine
- Renal failure: rare
- Renal impairment: 19-45%
- clarithromycin
- Renal failure: postmarketing
- Renal impairment: postmarketing
- clodronate
- Renal failure
- Renal impairment
- clofarabine
- clomiphene citrate
- clopidogrel
- Renal impairment: postmarketing
- clozapine
- Renal failure: postmarketing
- cobicistat
- copolymer 1
- Renal failure: postmarketing
- cyclophosphamide
- Renal failure: postmarketing
- Renal impairment: postmarketing
- cyproterone
- cyproterone acetate
- cysteamine
- dabrafenib
- Renal failure: uncommon, 0% - 7%
- dantrolene
- dapagliflozin
- darunavir
- Renal failure: uncommon
- Renal impairment
- dasatinib
- deferasirox
- deferoxamine
- Renal failure: postmarketing
- Renal impairment: very rare
- degarelix
- desflurane
- dextrorphan
- diatrizoate
- diazepam
- diclofenac
- dicloxacillin
- Renal failure: uncommon
- Renal impairment: uncommon
- diflunisal
- Renal failure
- Renal impairment
- diltiazem
- docetaxel
- Renal failure: postmarketing, rare
- Renal impairment: postmarketing, rare
- dolutegravir
- donepezil
- Renal failure: infrequent
- doxorubicin
- duloxetine
- efavirenz
- Renal failure
- Renal impairment
- emtricitabine
- Renal failure
- Renal impairment: postmarketing
- entecavir
- epinephrine
- eplerenone
- eprosartan
- eribulin
- erlotinib
- Renal failure
- Renal impairment
- etodolac
- Renal failure
- Renal impairment: postmarketing
- etoposide
- etoricoxib
- Renal failure: postmarketing
- Renal impairment: postmarketing
- etravirine
- everolimus
- Renal failure: common, 3%
- Renal impairment
- exenatide
- Renal failure
- Renal impairment: postmarketing, rare
- febuxostat
- fenofibrate
- Renal failure: postmarketing
- fenofibric acid
- Renal failure: postmarketing
- fenoprofen
- fentanyl
- Renal failure
- Renal impairment
- flecainide
- flucloxacillin
- fludarabine
- fluoxetine
- Renal failure
- Renal impairment
- flurbiprofen
- fluvoxamine
- Renal impairment: postmarketing
- foscarnet
- fosinopril
- fosinoprilat
- fosphenytoin
- Renal failure: infrequent
- furosemide
- gabapentin
- Renal impairment: postmarketing
- gadobenate dimeglumine
- gadodiamide
- Renal failure
- Renal impairment: postmarketing
- gadopentetate
- Renal impairment: postmarketing
- galantamine
- Renal failure: postmarketing, infrequent
- Renal impairment: postmarketing, infrequent
- ganciclovir
- Renal failure: 12%
- Renal impairment: 14%
- gemcitabine
- Renal failure: postmarketing, rare
- Progressive renal failure
- Renal impairment: postmarketing
- gemfibrozil
- gemifloxacin
- Renal failure: postmarketing
- gliclazide
- Renal failure
- Renal impairment
- hydrochlorothiazide
- ibandronate
- ibuprofen
- Renal failure: 1%
- Renal impairment: 6%
- ibutilide
- ifosfamide
- Renal failure: 1%
- Renal impairment: 6%
- iloprost
- imatinib
- Renal failure: infrequent, uncommon
- indapamide
- Renal failure: postmarketing
- indinavir
- Renal failure: postmarketing
- Renal impairment: postmarketing
- indomethacin
- Renal failure
- Renal impairment
- iodipamide
- iohexol
- iopamidol
- iopromide
- Renal failure: postmarketing
- Renal impairment
- iotrolan
- ioversol
- ioxilan
- irbesartan
- Renal failure: postmarketing
- Renal impairment: postmarketing
- irbesartan-hydrochlorothiazide
- Renal failure
- Renal impairment
- irinotecan
- Renal impairment: postmarketing
- itraconazole
- Renal failure
- Renal impairment: postmarketing
- ixabepilone
- ketoprofen
- Renal failure
- Renal impairment
- ketorolac
- ketorolac tromethamine
- lamivudine
- lamotrigine
- lansoprazole
- Renal failure
- Renal impairment
- leflunomide
- lenalidomide
- Renal failure: postmarketing, 1.49% - 3.73%
- lercanidipine
- linezolid
- liraglutide
- Renal impairment: postmarketing
- lithium carbonate
- lomefloxacin
- Renal failure: postmarketing
- lomustine
- losartan
- Renal failure
- Renal impairment: postmarketing
- loxapine
- lurasidone
- mannitol
- maraviroc
- meclofenamate
- mefenamic acid
- mefloquine
- meloxicam
- memantine
- Renal impairment: postmarketing
- meropenem
- methotrexate
- minocycline
- mitomycin C
- mitoxantrone
- moexiprilat
- morphine
- Renal failure
- Renal impairment
- moxifloxacin
- mycophenolate mofetil
- Renal failure
- Renal impairment
- mycophenolic acid
- Renal failure
- Renal impairment: 1%
- nabumetone
- nafcillin
- naproxen
- Renal failure: postmarketing
- nesiritide
- nevirapine
- nilotinib
- nitrofurantoin
- Renal failure
- Renal impairment
- norethisterone
- norfloxacin
- Renal failure: postmarketing
- ofloxacin
- Renal failure: postmarketing
- olmesartan
- omeprazole
- Renal impairment: very rare
- orlistat
- oxaprozin
- oxcarbazepine
- paclitaxel
- pamidronate
- parecoxib
- pemetrexed
- penicillin
- pentamidine
- Renal failure
- Renal impairment
- pentostatin
- Renal failure
- Renal impairment
- pergolide
- Renal failure: infrequent
- perindopril
- Renal impairment: uncommon
- perindopril erbumine
- Renal failure
- Renal impairment
- perindoprilat
- phenobarbital
- phenytoin
- Renal failure: infrequent
- phosphate
- piperacillin
- piroxicam
- Renal failure: postmarketing
- pomalidomide
- Renal failure: 6.25% - 15%
- posaconazole
- Renal failure
- Renal insufficiency aggravated
- Renal impairment
- pramipexole
- Renal failure
- Renal impairment
- prednisolone phosphate
- pregabalin
- procainamide
- propafenone
- Renal failure: postmarketing
- propofol
- quinapril
- quinaprilat
- quinidine
- Renal failure
- Renal impairment
- radium
- raltegravir
- Renal failure: uncommon
- Renal impairment
- raltitrexed
- ramipril
- Renal impairment: postmarketing
- ramiprilat
- Renal impairment: postmarketing
- ranolazine
- regadenoson
- remifentanil
- Renal failure: 0% - 2.44%
- Renal impairment: 0% - 2.84%
- retinoic acid
- Renal failure: postmarketing
- Renal impairment: 11%
- ribavirin
- Renal failure: rare
- Renal impairment: rare
- rifampicin
- rilpivirine
- risperidone
- ritonavir
- Renal failure
- Renal impairment: postmarketing
- rivaroxaban
- rivastigmine
- Renal failure: infrequent
- saquinavir
- Renal impairment: uncommon
- sevoflurane
- Renal failure: postmarketing
- sibutramine
- sildenafil
- sitagliptin
- Renal impairment: postmarketing
- sitaxsentan
- sodium
- Renal impairment: postmarketing
- solifenacin
- Renal impairment: postmarketing
- sorafenib
- Renal failure: postmarketing, common
- spironolactone
- streptomycin
- succinylcholine
- sulfamethoxazole
- sulindac
- Renal failure
- Renal impairment
- sunitinib
- Renal failure
- Renal impairment: postmarketing
- tacrolimus
- Renal failure: common
- Renal impairment: postmarketing, very common
- tadalafil
- telavancin
- Renal failure
- Renal impairment: uncommon
- telmisartan
- Renal failure
- Renal impairment: postmarketing, uncommon
- temsirolimus
- tenofovir
- Renal failure: postmarketing
- Renal impairment: postmarketing
- tenofovir disoproxil fumarate
- Renal failure: postmarketing, rare
- Renal impairment: postmarketing
- testosterone
- thalidomide
- Renal failure: postmarketing
- thiazide
- thiotepa
- thymidine
- tiagabine
- Renal failure: infrequent
- ticlopidine
- tiotropium
- tipranavir
- Renal failure: uncommon
- Renal impairment: uncommon
- tizanidine
- tobramycin
- tolmetin
- tolvaptan
- Renal impairment: uncommon
- topiramate
- tramadol
- Renal impairment: postmarketing, uncommon
- trametinib
- trandolapril
- trandolaprilat
- Renal failure: postmarketing
- Renal impairment: postmarketing
- tranexamic acid
- trimethoprim
- Renal impairment: very rare
- trimethoprim-sulfamethoxazole
- Renal failure: very rare
- Renal impairment: very rare
- v 1784
- Renal failure
- Progressive renal failure: postmarketing
- Renal impairment
- valganciclovir
- Renal failure
- Renal impairment: 1% - 12%
- valsartan
- Renal failure: postmarketing
- Renal impairment: very rare, postmarketing, common
- vandetanib
- venlafaxine
- Renal failure: postmarketing
- vinflunine
- ziprasidone
- zoledronic acid
- Renal failure
- Renal impairment: postmarketing, common
- zonisamide
|
Drugs with this indication
|